VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 669 filers reported holding VANECK VECTORS ETF TR in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $714 | -99.9% | 11 | -100.0% | 0.00% | -100.0% |
| Q3 2022 | $547,000 | -11.9% | 22,667 | 0.0% | 0.26% | -17.2% |
| Q2 2022 | $621,000 | -28.5% | 22,667 | 0.0% | 0.32% | -13.1% |
| Q1 2022 | $869,000 | +19.7% | 22,667 | 0.0% | 0.37% | +33.0% |
| Q4 2021 | $726,000 | +8.7% | 22,667 | 0.0% | 0.28% | -21.6% |
| Q3 2021 | $668,000 | -13.2% | 22,667 | 0.0% | 0.35% | -2.8% |
| Q2 2021 | $770,000 | +4.5% | 22,667 | 0.0% | 0.36% | -8.8% |
| Q1 2021 | $737,000 | -9.7% | 22,667 | 0.0% | 0.40% | -16.6% |
| Q4 2020 | $816,000 | -8.1% | 22,667 | 0.0% | 0.48% | -30.0% |
| Q3 2020 | $888,000 | +6.9% | 22,667 | 0.0% | 0.68% | -6.8% |
| Q2 2020 | $831,000 | +59.2% | 22,667 | 0.0% | 0.73% | +22.9% |
| Q1 2020 | $522,000 | -21.4% | 22,667 | 0.0% | 0.59% | -3.7% |
| Q4 2019 | $664,000 | – | 22,667 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hollow Brook Wealth Management LLC | 711,589 | $25,631,000 | 15.27% |
| Sloane Robinson LLP | 450,000 | $16,209,000 | 15.04% |
| New Harbor Financial Group, LLC | 1,103,389 | $39,744,000 | 14.30% |
| Brown University | 541,096 | $19,490,000 | 14.10% |
| Grand Central Investment Group | 426,777 | $15,373,000 | 13.75% |
| New Harbor Financial Group, LLC | 1,055,400 | $38,015,000 | 13.68% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $26,601,000 | 11.26% |
| Brevan Howard Capital Management LP | 1,420,000 | $51,148,000 | 10.26% |
| Nokomis Capital, L.L.C. | 603,528 | $21,739,000 | 9.52% |
| tru Independence LLC | 139,120 | $5,011,102,000 | 9.10% |